AIRA MOTS-c injectable vial
Longevity

MOTS-c Peptide

Starting at
169.15
/month*

MOTS-c peptide therapy uses a lab-made version of a peptide your mitochondria make naturally, studied for its role in cellular energy and healthy aging, prescribed only when a licensed provider determines it is appropriate.

  • Studied for how cells produce and use energy
  • Researched for its links to exercise and muscle
  • Explored for its role in healthy aging
  • Investigated for effects on metabolic balance
Get started

How It Works

MOTS-c peptide therapy is based on research into a small peptide made by mitochondria, the parts of your cells that produce energy. In animal and lab studies, MOTS-c helped muscle cells respond to insulin and use fuel more efficiently, partly by activating AMPK, a cellular energy sensor. Natural MOTS-c levels rise with exercise in humans and appear to decline with age. Treatment studies so far have been in animals, so your provider can help you weigh what is known.

Discovery & Testing Background

MOTS-c was discovered in 2015 by researchers at the University of Southern California, who found it encoded in the DNA of mitochondria rather than in the cell's nucleus. Their early studies in mice linked it to healthier metabolism and insulin sensitivity.

Later research showed that exercise raises MOTS-c levels in human muscle and blood, and that older mice given MOTS-c showed better physical capacity. A closely related compound has been tested in early human trials, but MOTS-c itself has not completed published human trials.

What Is MOTS-c?

MOTS-c is a lab-made version of a 16-amino-acid peptide that the body makes naturally in its mitochondria. Its name stands for mitochondrial open reading frame of the 12S rRNA-c, which describes where its genetic code is found.

MOTS-c is not an FDA-approved drug. It is available only as a compounded medication, prescribed by a licensed provider and prepared by a licensed 503A compounding pharmacy for an individual patient.

Key Takeaways

Made by Mitochondria

A natural peptide encoded in mitochondrial DNA, discovered in 2015.

Linked to Exercise

Published research shows human MOTS-c levels rise with exercise.

Studied for Healthy Aging

Older mice given MOTS-c showed better physical capacity.

Physician-Guided Access

Prescribed only after a licensed provider reviews your health history.

Safety & Side Effects

Reported side effects of MOTS-c have generally been mild, most often redness or discomfort at the injection site. A placebo-controlled trial of a closely related compound reported no serious side effects. Because MOTS-c itself has not completed human trials, its full side effect profile is not yet known.

MOTS-c is not approved by the FDA. In October 2026, the U.S. Department of Health and Human Services issued an interim enforcement policy that sets specific quality and safety conditions for compounding MOTS-c while the FDA completes its formal review. This policy is not an FDA approval.

Because MOTS-c is studied for its effects on blood sugar, people with diabetes or who take glucose-lowering medication should discuss it with their provider first. Pregnant or breastfeeding individuals should avoid it, and competitive athletes should confirm its status under anti-doping rules. A licensed provider reviews your health history before any prescription is written, and you can reach a provider at any time with questions.
Clinician inspecting a vial of AIRA MOTS-c

Quality & Specifications

When prescribed, MOTS-c is prepared for you as an individual patient by an independent, state-licensed 503A compounding pharmacy. Under federal law and current HHS policy, the active ingredient must come from an FDA-registered manufacturer and arrive with a certificate of analysis documenting its identity, purity, potency, and testing for contaminants such as endotoxins and microbes.

The pharmacies AIRA works with are licensed in Texas and follow Texas State Board of Pharmacy rules for sterile compounding.

Molecular Profile

FORMULA
C101H152N28O22S2 (supplied as the acetate salt)
WEIGHT
2174.6 g/mol (peptide only)
CAS
1627580-64-6
SEQUENCE
Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg

Physical Properties

FORM
White powder (active ingredient)
SOLUBILITY
Dissolves readily in water
STABILITY
The dispensing pharmacy assigns a beyond-use date on the label
STORAGE
Store as directed on your pharmacy label, typically refrigerated at 36-46 °F (2-8 °C)
​

See the Science

Below are peer-reviewed or preclinical research items with straightforward summaries.

The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance2015 · Preclinical study

In mice and cell studies, MOTS-c improved insulin sensitivity and metabolic balance, mainly in skeletal muscle.
Read Study

MOTS-c Is an Exercise-Induced Mitochondrial-Encoded Regulator of Age-Dependent Physical Decline and Muscle Homeostasis2021 · Human and animal study

Exercise raised MOTS-c levels in human muscle and blood, and older mice given MOTS-c showed improved physical capacity.
Read Study

MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases2022 · Review

This review summarizes research on MOTS-c and aging, including how its levels change over time and its effects on metabolism and muscle in animal studies.
Read Study
AIRA encourages all patients to conduct their own research and consult with a qualified healthcare provider before beginning any peptide or prescription therapy. While we strive to provide accurate, science-based information, much of the existing research on compounds such as MOTS-c is derived from preclinical or early-stage studies. These findings may not yet be fully validated in large-scale human trials. The content provided on this site is for informational and educational purposes only and should not be interpreted as medical advice or a guarantee of treatment efficacy. Individual results may vary based on health history, dosing, and other factors. Always discuss potential risks, benefits, and alternative options with your doctor or licensed medical provider prior to starting any new therapy.

Why AIRA for MOTS-c?

AIRA connects you with licensed providers who review your health history and goals before deciding whether MOTS-c is appropriate. If it is prescribed, your medication is prepared by an independent, state-licensed 503A compounding pharmacy and shipped discreetly to your door. You can message a provider at any time with questions and track your prescriptions and progress from one dashboard.

Get started
AIRA support chat conversation with client

Chat with a provider 24/7

Connect instantly with a provider anytime, day or night. No appointments, no waiting.
Medical app verification icon with checkmark and medicine symbol

Trusted pharmacy

Prescriptions are filled through licensed, accredited pharmacies for safety and peace of mind.
AIRA healthcare ecosystem illustration with medical icons

Manage goals in one place

Track your progress, prescriptions, and provider guidance all from a single, easy-to-use dashboard.
Fast delivery and easy returns icon for product shipping and logistics.

Fast, discreet shipping

Treatments are discreetly packaged and delivered promptly to your doorstep.
MOTS-c

Explore MOTS-c with a licensed provider.

Complete a short online health questionnaire. A licensed provider will review it and determine whether MOTS-c is appropriate for you.

Get started
See if you're eligible
AIRA MOTS-c injectable vial on a stone ledge with glowing mitochondria behind it

What our customers say about AIRA

Hear from patients about their experience with AIRA's online care and delivery.
Get started
​
​
​
​
​
I came to AIRA looking to address recovery and inflammation from disc herniations, and started a BPC-157 and TB-500 protocol three weeks ago. The process has been seamless from onboarding to delivery, and the team has been responsive throughout. Still early days, but I'm encouraged enough to have already placed my reorder, a solid addition to my routine so far.
Bryan W., Detroit
Verified AIRA customer
​
​
​
​
​
​
I have been working with AIRA since they launched. They are a trusted source for my medication and the ability to get it shipped directly to my home saves me time and money! I am so happy I found them and I look forward to continuing to work with them in the future!
Jeff, Miami
Verified AIRA customer
​
​
​
​
​
​
After years in the peptide space, AIRA is only my second supplier and that's intentional. What sets them apart is the integrity behind how they operate; you can tell they're building this the right way. Ordering is seamless, shipping is fast, and most importantly, I trust what's in the vial. Their lab-tested peptides give me full confidence every time.
Rob, Los Angeles
Verified AIRA customer
​

Frequently asked questions

Is MOTS-c FDA-approved?

MOTS-c has not been approved by the U.S. Food and Drug Administration. It can only be prescribed through licensed clinicians where state law allows, and it is available only as a compounded medication prepared for an individual patient.

Has MOTS-c been studied in humans?

Not yet in completed published trials. Studies have measured natural MOTS-c levels in people, finding they rise with exercise, and a closely related compound has been tested in early human trials. Treatment research on MOTS-c itself has been in animals and cells.

What is MOTS-c being studied for?

MOTS-c is being studied for its role in cellular energy, metabolic balance, and physical function with age. In animal research, it improved insulin sensitivity and physical capacity in older mice. These findings have not yet been confirmed in human trials.

What side effects have been reported with MOTS-c?

Reported side effects have generally been mild, most often redness or discomfort at the injection site. Because MOTS-c has not completed human trials, its full side effect profile is not yet known. Use should be guided by a licensed provider who can help monitor how you respond.

Who should avoid MOTS-c?

Pregnant or breastfeeding individuals should not use MOTS-c. People with diabetes, those taking glucose-lowering medication, and competitive athletes subject to anti-doping rules should discuss it with their provider first.

How is MOTS-c administered?

AIRA's MOTS-c is prescribed as a subcutaneous injection, meaning a small injection just under the skin. Your provider and your pharmacy label will explain how to use it.

Do I need a prescription for MOTS-c?

Yes. MOTS-c is available only with a prescription from a licensed provider, written for you as an individual patient.

How does AIRA's online process work?

You complete an online health questionnaire, and a licensed provider reviews it to decide whether treatment is appropriate. If your state requires a live consultation, one is arranged before any prescription is written. If approved, an independent 503A compounding pharmacy prepares your medication and ships it to you.

How is the quality of MOTS-c verified?

The active ingredient must come from an FDA-registered manufacturer and arrive with a certificate of analysis documenting its identity, purity, potency, and contaminant testing. The compounding pharmacy then prepares your medication under Texas State Board of Pharmacy sterile compounding rules.

Can MOTS-c peptide therapy be combined with other treatments?

Some patients use MOTS-c alongside other single-ingredient treatments, such as NAD+, with each prescribed separately. Whether combining treatments makes sense for you is a decision for your provider, based on your health history and goals.

Still have questions?
​
Contact support

Related Treatments

​
See all treatments
TB-500
Accelerated Healing
169.15
/month*
AIRA TB-500 injectable vial
Get started
Learn more
Epitalon
Longevity
199.00
/month*
AIRA Epitalon injectable vial
Get started
Learn more
BPC-157
Accelerated Healing
169.15
/month*
AIRA BPC-157 injectable vial
Get started
Learn more